# A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy

> **NCT03371550** · PHASE2 · COMPLETED · sponsor: **Centre Antoine Lacassagne** · enrollment: 44 (actual)

## Conditions studied

- Locally Advanced Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Docetaxel
- **RADIATION:** concomitant radiotherapy
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT03371550
- **Lead sponsor:** Centre Antoine Lacassagne
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08-05
- **Primary completion:** 2010-10-31
- **Final completion:** 2011-10-31
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2017-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03371550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03371550, "A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03371550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*